4//SEC Filing
FIER IAN 4
Accession 0001179110-20-010055
CIK 0001235010other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 5:03 PM ET
Size
24.8 KB
Accession
0001179110-20-010055
Insider Transaction Report
Form 4
FIER IAN
Chief Mfg and Program Officer
Transactions
- Disposition to Issuer
Restricted Stock Units
2020-10-01−21,938→ 0 total→ Common Stock (21,938 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2020-10-01−52,808→ 0 totalExercise: $12.76Exp: 2029-02-11→ Common Stock (52,808 underlying) - Disposition to Issuer
Restricted Stock Units
2020-10-01−1,425→ 0 total→ Common Stock (1,425 underlying) - Disposition to Issuer
Restricted Stock Units
2020-10-01−45,000→ 0 total→ Common Stock (45,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2020-10-01−20,192→ 0 totalExercise: $12.76Exp: 2029-02-11→ Common Stock (20,192 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2020-10-01−99→ 0 totalExercise: $18.85Exp: 2027-02-07→ Common Stock (99 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2020-10-01−76,378→ 0 totalExercise: $31.87Exp: 2030-02-07→ Common Stock (76,378 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2020-10-01−2,751→ 0 totalExercise: $18.85Exp: 2027-02-07→ Common Stock (2,751 underlying) - Disposition to Issuer
Restricted Stock Units
2020-10-01−40,000→ 0 total→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2020-10-01−3,622→ 0 totalExercise: $31.87Exp: 2030-02-07→ Common Stock (3,622 underlying)
Footnotes (2)
- [F1]Reflects disposition of Issuer restricted stock units in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020 (the "Merger Agreement"), by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the "Effective Time"), each Issuer restricted stock unit held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer restricted stock unit immediately prior to the Effective Time by (y) $52.50 per share in cash, without interest, less any required withholding taxes (the "Offer Price").
- [F2]Reflects disposition of options to acquire shares of Issuer common stock (each, an "Issuer Option") in accordance with the Merger Agreement, pursuant to which, effective immediately prior to the Effective Time, each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which the Offer Price exceeds the per share exercise price of such Issuer Option.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeother
Related Parties
1- filerCIK 0001755118
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 5:03 PM ET
- Size
- 24.8 KB